Lung cancer cocktail trial halted early
NCT ID NCT04619433
First seen Sep 30, 2025 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This study tested a combination of three drugs—SHR-1210, famitinib, and chemotherapy—in people with advanced non-squamous lung cancer that had not been treated before. The goal was to see if the combo could slow cancer growth and be safe. The trial was stopped early and included 48 adults aged 18-70.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Cancer Hosipital
Beijing, Beijing Municipality, 100089, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450003, China
-
Hubei Cancer Hospita
Wuhan, Hubei, 430079, China
-
Shanghai Lung Hospital
Shanghai, Shanghai Municipality, 200433, China
-
Shengjing Hospita of China Medical University
Shenyang, Liaoning, 110022, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, 300060, China
-
West China Hospital，Sichuan University
Chengdu, Sichuan, 610000, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.